Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.06

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.06). Revenue for the quarter came in at $8.3 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick
• After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI